Position in ALKS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$498,795
-$23,848,792 QoQ
Shares Held
9,519
-98.6% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#242
of 424 holders
Holding Since
Dec 2020
13 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALKS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Pacer Advisors, Inc. holds $406,344,526 across 19 Drug Manufacturers - Specialty & Generic names. ALKS ranks #15 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
1,556,307 | $111,836,221 | |
| 2 | VTRS |
Viatris Inc
|
5,928,142 | $94,138,894 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
155,398 | $84,199,298 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
419,770 | $70,748,035 | |
| 5 | COLL |
Collegium Pharmaceutical, Inc
|
277,282 | $10,037,608 | |
| 6 | PBH |
Prestige Consumer Healthcare Inc.
|
186,134 | $8,798,554 | |
| 7 | ANIP |
Ani Pharmaceuticals Inc
|
81,486 | $6,745,411 | |
| 8 | PCRX |
Pacira BioSciences, Inc.
|
212,814 | $5,399,091 |
All Filings in ALKS
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $498,795 | 9,519 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $24,347,587 | 688,563 | Shares | Sole | 2026-06-18 | |
| 2025-12-31 | $18,882,974 | 674,874 | Shares | Sole | 2026-02-24 | |
| 2025-09-30 | $24,243,960 | 808,132 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $25,948,039 | 906,957 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $29,392,554 | 890,144 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $99,598,238 | 3,463,082 | Shares | Sole | 2025-01-22 | |
| 2024-09-30 | $116,589,266 | 4,165,390 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $135,939,472 | 5,640,642 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $115,820,700 | 4,278,563 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $21,359 | 770 | Shares | Sole | 2024-01-16 | |
| 2021-03-31 | $74,981 | 4,014 | Shares | Sole | 2021-04-05 | |
| 2020-12-31 | $124,567 | 6,244 | Shares | Sole | 2021-01-20 | |
| No filing history on record for this holder in this stock. | ||||||